Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.

No cookies to display.

Sick Economics

Searching For Healthy Profits In The Stock Market

Biotech Investing

Biotech Investing

Biotech investing means betting on scientific innovation. Let’s talk about how you can turn innovation into profit.

 

bluebird bio split two companies
10 min read

By Aidan Asbill, Biotech Analyst    In 2018, Bluebird Bio’s ($BLUE) impressive cell-based therapies propelled the company to stock prices...

potential biotech acquisition targets
7 min read

By John Kehoe, Equity Analyst   In the biotech industry, companies that are successfully developing medicine rarely go bankrupt. These...

12 min read

By Aidan Asbill, Biotech Analyst    Intellia Therapeutics ($NTLA) shocked the gene-editing field with the announcement of data from the...

promising neuroscience companies
7 min read

By Owen Marino, Biotech Analyst   Arguably the hottest topic in biotech this past month has been the approval of...

undervalued biopharmaceutical stocks
10 min read

By John Kehoe, Equity Analyst   Valuation within the biotech industry can be extremely difficult. Many biotech and pharmaceutical companies...

Illumina Stock ILMN Worth The Risk
7 min read

By John Kehoe, Equity Analyst    When searching for potentially rewarding investments within the biotech industry, it is helpful to...